Dxb share price asx
WebASX:DXB profile with today’s share price, announcements, live price charts, upcoming dividends, annual reports and investor calendar WebAug 16, 2024 · ASX:DXB DXB is a $46M ASX listed biotech company that has developed a treatment for inflammatory diseases, such as kidney and respiratory diseases, and also has applications for treating COVID related lung inflammation.
Dxb share price asx
Did you know?
WebDXB share price and company information for ASX:DXB. Refresh Data. Market data is provided and copyrighted by Thomson Reuters and Morningstar. Click for restrictions. … WebDXB UNATTRACTIVE : Dimerix exhibits an implied growth ratio which exceeds the industry average for pharmaceuticals, biotechnology & life sciences stocks listed on the ASX. DXB calculation: 10% - (-$0.07 / $0.12) = 67.5% Implied Growth explained Price / Book 2.0 1.3 Industry Avg DXB
WebDimerix Ltd (ASX: DXB) Share Price and News Price Movement (20 mins delayed) 52 Week Range - 1 Year Return Dimerix Limited Chart and Price Data Fundamentals Data … WebMar 29, 2024 · DXB:ASX trading volume exceeds daily average by +17.35% Feb 27 2024 Key statistics On Wednesday, Dimerix Ltd (DXB:ASX) closed at 0.115, 9.52% above its …
WebApr 27, 2024 · ASX:DXB Published 27-APR-2024 14:25 P.M. Price: $0.140 10 minute read Disclosure: The authors of this article and owners of Next Investors, S3 Consortium Pty Ltd, and associated entities, own 2,825,000 DXB shares at the time of publication. WebHow has the Dimerix share price performed this year? Shares in Dimerix last closed at AU$0.11 and the price had moved by -40% over the past 365 days. In terms of relative …
WebGet the latest ASX Ltd (ASX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
WebThe latest stock prices for Dimerix (ASX:DXB), market announcements, articles, fundamentals, trends, sentiment, charts, discussion and more. Track ASX codes like … in004-15bxWebAug 16, 2024 · The Phase 2 trial results for DXB’s Diabetic Kidney Disease drove up the DXB share price from March 2024 to Sept 2024, and the DXB share price settled at around ~25¢ after trading at around 10¢ for the previous year (with a big spike up to almost 80¢ before the trials). in-005 ourairportsWebNov 28, 2024 · Given that it has a beta of 1.81, we can surmise that the Dimerix share price has been fairly sensitive to market volatility (over the last 5 years). Based on this history, … lithonia ll16WebApr 10, 2024 · Summary of all time highs, changes and price drops for Dimerix; Historical stock prices; Current Share Price: AU$0.096: 52 Week High: AU$0.18: 52 Week Low: … lithonia lk4bmw ledWebInsiders who acquired AU$4.0m worth of Dimerix Limited's ( ASX:DXB ) stock at an average price of AU$0.21 in the past... Simply Wall St. We Think Dimerix (ASX:DXB) Needs To … in004/2021/sg/seduc/mtWebDimerix Ltd (ASX:DXB) Share Price - Market Index ASX Indices Stock Scans Commodities Popular Pages Plans & Portfolios Dimerix Ltd (DXB) ___: ___ · Healthcare ASX Delayed … lithonia lk5bmw led replacementWebMay 28, 2024 · Neuren Pharmaceuticals (ASX:NEU) share price chart Telix Pharmaceuticals (ASX:TLX) This $1.2 billion ASX biotech stock has a Phase III trial evaluating TLX250-CDx as a diagnostic agent targeting clear cell Renal Cell Carcinoma (ccRCC) in 252 patients across Australia and North America. in 008 cbmsc